Ginkgo Bioworks Holdings (DNA) Inventory Average (2021 - 2023)
Ginkgo Bioworks Holdings (DNA) reported Inventory Average of $230500.0 for Q3 2023, down 96.7% on a YoY basis from $7.0 million in Q3 2022, and down 84.1% quarter-over-quarter from $1.4 million in Q2 2023.
Ginkgo Bioworks Holdings (DNA) Inventory Average (2021 - 2023) Analysis & Trends
Ginkgo Bioworks Holdings has reported Inventory Average for 3 years, with the latest figure at $230500.0 in Q3 2023.
- For the quarter ending Q3 2023, Inventory Average fell 96.7% year-over-year to $230500.0; the trailing twelve-month figure through Sep 2023 stood at $230500.0 (down 96.7% YoY), and the FY2022 full-year result was $3.9 million, up 26.7% from the prior year.
- Inventory Average for Q3 2023 stood at $230500.0, down from $1.4 million in the prior quarter.
- The five-year high for Inventory Average was $8.4 million in Q2 2022, with the low at $230500.0 in Q3 2023.
- Historically, Inventory Average has averaged $4.4 million across 3 years, with a median of $4.3 million in 2022.
- Annual changes were most pronounced in 2022 — Inventory Average soared 49.56% — and 2023, when it slumped 96.7%.
- Ginkgo Bioworks Holdings' Inventory Average stood at $3.4 million in 2021, then jumped by 49.56% to $5.1 million in 2022, then tumbled by 95.49% to $230500.0 in 2023.
- The last three Inventory Average figures came in at $230500.0 (Q3 2023), $1.4 million (Q2 2023), and $3.4 million (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ginkgo Bioworks Holdings | 546.79 Mn | 546.79 Mn | 16.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 230,500.00 |
| Jun 30, 2023 | 1.45 Mn |
| Mar 31, 2023 | 3.44 Mn |
| Dec 31, 2022 | 5.11 Mn |
| Sep 30, 2022 | 6.98 Mn |
| Jun 30, 2022 | 8.40 Mn |
| Mar 31, 2022 | 6.03 Mn |
| Dec 31, 2021 | 3.42 Mn |